ArticleJournal of the Endocrine Society2026
One-hour postload glucose compared to prediabetes criteria as predictive markers of type 2 diabetes in Latin America.
Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Glycemia-based predictors of T2D development in adults with obesity and prediabetes: SURMOUNT-1 post hoc analysis.Journal of the Endocrine Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Background: One-hour postload glucose (1h-PG) ≥ 155 mg/dL has been proposed as a marker of prediabetes and risk for type 2 diabetes (T2DM). However, direct comparison with other prediabetic criteria, also in different populations, could improve the prognostic approach for T2DM. Objective: This study compared the prognostic value 1h-PG to traditional prediabetes criteria. Methods: A cohort of 321 Peruvian patients with histories of impaired fasting glucose (IFG) underwent OGTTs and were followed for 7 years for T2DM development. Results: Based on the OGTT, 56.6% of patients had confirmed IFG, 75.4% had normal glucose tolerance (NGT), and 24.6% exhibited IGT. Among NGT individuals, 58.7% had 1h-PG < 155 mg/dL and 41.3% presented 1h-PG ≥ 155 mg/dL. Elevated 1h-PG was associated with IFG, higher body mass index, glycated hemoglobin A1c, and plasma uric acid. Among those tested, 56% had glycated hemoglobin A1c ≥ 5.7%. Concordance between 1h-PG and prediabetes markers was weak. After 4.6 years, 24.3% of patients developed T2DM. Incidence was higher in those with 1h-PG ≥ 155 mg/dL (36.1%) and IGT (32.9%). Only IFG and 1h-PG ≥ 155 mg/dL were significantly associated with T2DM risk, with the latter showing the highest risk (risk ratio = 2.91; 95% CI [1.71-5.19]; Conclusion: 1h-PG ≥ 155 mg/dL is a solid predictor of T2DM, even among individuals with NGT, and may serve as a useful diagnostic criterion for prediabetes in Latin American populations and may be helpful to define a prediabetic phenotype.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.